Clinical trial
Randomized Placebo-Controlled Study of Sildenafil For The Treatment of Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis: A Pilot Study
NCT00625079 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Placebo-Controlled Study of Sildenafil For The Treatment of Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis: A Pilot Study
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- February 28, 2007
- Completion date
- December 31, 2009
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic pulmonary fibrosis, interstitial lung disease, pulmonary arterial hypertension, pulmonary hypertension